- Home
- / REYON Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
REYON Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩16.3 K
2024-10-29
Market Capitalization
₩301 B
2024-10-29
Revenue
₩145.9 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 123.0B | 131.6B | 130.0B | 142.8B | 154.0B | 151.1B | 148.3B | 145.9B |
| Cost of goods sold | 42.6B | 49.5B | 46.9B | 48.8B | 59.4B | 72.0B | 73.3B | 107.7B |
| Gross profit | 80.5B | 82.5B | 84.1B | 94.6B | 95.7B | 82.4B | 77.1B | 40.8B |
| Gross profit margin, % | 65.4% | 62.7% | 64.7% | 66.3% | 62.1% | 54.6% | 52.0% | 28.0% |
| Operating expense total | 76.1B | 72.2B | 77.0B | 85.6B | 85.7B | 74.8B | 69.6B | 69.8B |
| Depreciation and amortization | 1.9B | 2.0B | 2.0B | 4.7B | 4.5B | 2.5B | 6.3B | |
| EBITDA | 4.3B | 9.9B | 6.6B | 10.7B | 8.0B | 6.7B | 3.1B | (27.3B) |
| EBITDA margin, % | 3.5% | 7.6% | 5.1% | 7.5% | 5.2% | 4.4% | 2.1% | -18.7% |
| EBIT | (731.4M) | 6.2B | 3.9B | 5.6B | 1.6B | 3.5B | (3.9B) | (27.4B) |
| EBIT margin, % | -0.6% | 4.7% | 3.0% | 3.9% | 1.0% | 2.3% | -2.6% | -18.8% |
| Interest income | 2.1B | 1.7B | 619.1M | 522.3M | 975.5M | 576.5M | 125.7M | 16.1B |
| Interest expense | 536.7M | 116.3M | 178.0M | 111.2M | 122.2M | 195.5M | 1.3B | 13.3B |
| Pre tax profit | 848.5M | 7.8B | 4.4B | 5.8B | 6.9B | 4.0B | 5.2B | (24.6B) |
| Income tax expense | (493.0M) | 1.9B | 523.3M | 307.5M | (539.8M) | 448.6M | 1.0B | 5.0B |
| Net Income | 1.3B | 5.9B | 3.8B | 5.5B | 7.4B | 3.6B | 4.2B | (29.6B) |